Di Wu

1PUBLICATIONS
11CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 12, 2022
Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Triple-Negative Breast Cancer.

Peng Peng, Xiaoyan Qiang, Guoyu Li

Pageof 1

Frequent Collaborators

1 joint publications

Peng Peng

1 joint publications

Xiaoyan Qiang

1 joint publications

Guoyu Li

1 joint publications

Lin Li